Close Menu

digital PCR

NEW YORK (GenomeWeb) ― Manipulating miniature droplets and subjecting them to high temperatures on an open digital microfluidic device leads to evaporation that can seriously disrupt concentration-dependent enzymatic reactions, like PCR.

NEW YORK (GenomeWeb) — Seattle-based start-up Lamprogen, a spinout of the University of Washington, is using funding from two grants to further the development of a self-digitizing microfluidic chip and instrument on which the chip will run.

NEW YORK (GenomeWeb) — Virologists at the University of Washington and the Fred Hutchinson Cancer Research Center recently reported that in a small, retrospective study droplet digital PCR appeared to have no added benefit over qPCR for clinical monitoring of human cytomegalovirus load in transpl

NEW YORK (GenomeWeb) — Researchers from Virginia Commonwealth University have developed a method of quantifying multiple nucleic acid targets in a single sample by combining low-cycle-number, target-specific PCR with atomic force microscopy.

NEW YORK (GenomeWeb) — RUCDR Infinite Biologics, the research services and biorepository arm of the Rutgers University Cell and DNA Repository (RUCDR), has been named a RainDance Technologies Center of Excellence, the partners said this week.

NEW YORK (GenomeWeb) — RUCDR Infinite Biologics, the research services and biorepository arm of the Rutgers University Cell and DNA Repository (RUCDR), has been named a RainDance Technologies Center of Excellence, the partners said today.

NEW YORK (GenomeWeb) — Bay Area startup Toma Biosciences emerged from stealth mode this month with a new cancer assay designed to provide physicians with information to help them personalize and optimize treatments for cancer patients.

Bio-Rad Laboratories this week announced an expansion of its PrimePCR probe assays for Droplet Digital PCR, adding 56 assays for mutation detection and 109 assays for copy number variation analysis to the company's existing catalog for the QX100 and QX200 Droplet Digital PCR systems.

NEW YORK (GenomeWeb News) — Researchers have linked low copy-number levels of the salivary amylase gene to obesity risk, a finding they reported in Nature Genetics yesterday.

Researchers from several European institutions have used a clinical trial of children with stage IV neuroblastoma to test prospectively whether varying levels of several mRNA markers could stratify patients according to their outcomes.

Pages

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.